[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-345307-105":59,"doc-detail-345307-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","burden-of-womens-cancers-in-the-group-of-twenty-g20-from-1990-to-2023-epidemiological-trends-and-impact-from-fertility-quality-of-care-and-survival","Burden of women's cancers in the group of twenty (G20) from 1990 to 2023 - epidemiological trends and impact from fertility, quality of care, and survival","","Women's cancers impose a major disease burden and create challenges for prevention, treatment, and caregiving. This study evaluates epidemiological trends and key drivers of women’s cancer burden in the G20 from 1990 to 2023, focusing on incidence, prevalence, mortality, and disability-adjusted life years. Data from the Global Burden of Disease Study 2023 are analyzed using age-standardized rates, a quality of care index, and 5-year relative survival, alongside trend and decomposition methods.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/burden-of-womens-cancers-in-the-group-of-twenty-g20-from-1990-to-2023-epidemiological-trends-and-impact-from-fertility-quality-of-care-and-survival/345307/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/burden-of-womens-cancers-in-the-group-of-twenty-g20-from-1990-to-2023-epidemiological-trends-and-impact-from-fertility-quality-of-care-and-survival/345307.png","ImageObject",300,407,{"name":92,"@type":93},"Oliver","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-11","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Which women’s cancers and outcomes are analyzed in the study?","Question",{"text":112,"@type":113},"The study analyzes breast, cervical, uterine, and ovarian cancers and reports incidence, prevalence, mortality, and disability-adjusted life years (DALYs).","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What data sources and metrics are used to study the trends?",{"text":117,"@type":113},"Incidence, prevalence, mortality, and DALYs come from the Global Burden of Disease Study 2023. Age-standardized rates, a quality of care index (QCI), and 5-year relative survival are calculated for integrated women’s cancers.",{"name":119,"@type":110,"acceptedAnswer":120},"What were the main drivers of changes in women’s cancer burden from 1990 to 2023?",{"text":121,"@type":113},"The increase from 1990 to 2023 was primarily driven by population growth, while fertility and changes in DALY-related rates for breast and cervical cancers show opposite directions of association. Dominance analysis identified fertility, QCI, and survival-related factors as dominant predictors.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},345307,1790242078,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},8796095461610,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Li et al. Mil Med Res 2026  \n[https://doi.org/10.1016/j.mmr.2026.100026](https://doi.org/10.1016/j.mmr.2026.100026)  \nRESEARCH Open Access  \nBurden of women's cancers in the group of twenty (G20) from 1990 to 2023: epidemiological trends and impact from fertility, quality of care, and survival  \nMeng-Long Li1,2†, Rui-Shu Tang2†, Nan Wang3†, Jin-Lei Qi4†, Hui-Ming He1, Meng-Ying Guan1, Miao Li1, Bing-Qing Wu1, Yeerlin Asihaer1, Sten H. Vermund5 andYi-Fei Hu1,6*  \nAbstract  \nBackground: Cancer in women represents a significant disease burden, posing challenges for prevention, treatment, and caregiving. This study aimed to analyze the epidemiological trends of the women’s cancer burden and the main influencing factors in the group of twenty (G20) from 1990 to 2023.  \nMethods: Incidence, prevalence, mortality, and disability-adjusted life years (DALYs) for breast, cervical, uterine, and ovarian cancers, as well as fertility rates for G20 and its 98 locations, were sourced from the Global Burden of Disease Study 2023. Age-standardized rates (ASRs), quality of care index (QCI), and 5-year relative survival of integrated women’s cancers were calculated. Average annual percent changes (AAPCs) were used to determine the temporal trends by age and region. Decomposition analysis identified drivers of changes in case numbers, linear regression assessed the associations with DALY rate changes, and dominance analysis identified dominant predictors.  \nResults: In 2023, the incidence, prevalence, mortality, and DALYs from women’s cancers in G20 were 3.29 [95% uncertainty interval (UI) 2.60–4.14], 26.71 (95% UI 21.99–32.40), 1.16 (95% UI 0.91–1.45), and 36.58 million (95% UI 28.40–46.32), respectively, with ASRs of 87.63/100,000 (95% UI 65.12–115.85), 706.16/100,000 (95% UI 555.75–890.02), 30.03/100,000 (95% UI 22.10–39. 58), and 994.79/100,000 (95% UI 728 .43–1328.81) . The QCI was 75.13 [95% confidence interval (CI) 73.67–76.59], and the 5-year relative survival rate was 65.74%(95% CI 65.53–65.95) . From 1990 to 2023, there was a significant increase in incidence, prevalence, mortality, and DALYs in G20, primarily driven by population growth. Age-standardized incidence rate, QCI, and 5-year relative survival increased, while age-standardized mortality and DALY rates decreased. Changes in prevalence rates of breast cancer and cervical cancer for women aged 15–49 years were positively associated with changes in DALY rates of women’s cancers, whereas changes in the total fertility rate were negatively associated. Dominance analysis confirmed these three factors consistently as dominant predictors between 1990 and 2023. Reducing the prevalence of breast and cervical cancers and increasing fertility among women aged 15–49 years could lower the overall DALY burden attributable to women’s cancer.  \nConclusions: The incidence, prevalence, mortality, and DALYs of women’s cancers in G20 have increased substantially from 1990 to 2023. Tailored prevention strategies should consider age and cancer type, emphasizing reproductive health for women of reproductive age.  \nKey words Women’s cancers, Global burden of diseases, Survival, Dominance analysis, Fertility  \nBackground  \nAccording to global cancer statistics, cancer accounted for 8.99 million and 9.66 million new cases and 4.61 million and 4.31 million deaths among women in 2023 and 2022, respectively, as reported by the Global Burden of Disease Study and Global Cancer Observatory [ 1,2 ] . Breast cancer, cervical cancer,  \n†Meng-Long Li, Rui-Shu Tang, Nan Wang, and Jin-Lei Qi contributed equally to this work  \n*Correspondence: Yi-Fei Hu, [huyifei@yahoo.com](huyifei@yahoo.com)  \n1Department of Child, Adolescent Health and Maternal Care, School of Public Health, Capital Medical University, Beijing 100069, China  \nFull list of author information is available at the end of the article  \novarian cancer, and uterine cancer collectively accounted for 38.3% of new cases and 30.7% of deaths among all cancersi","cbCaigl8ClRv1Jsi","https://ap.wps.com/l/cbCaigl8ClRv1Jsi","pdf",4067611,14,"English","# Background\n# Methods\n# Results\n## Key findings for 2023\n## Trends and driving factors (1990–2023)\n# Conclusions\n# Key words","[{\"question\":\"Which women’s cancers and outcomes are analyzed in the study?\",\"answer\":\"The study analyzes breast, cervical, uterine, and ovarian cancers and reports incidence, prevalence, mortality, and disability-adjusted life years (DALYs).\"},{\"question\":\"What data sources and metrics are used to study the trends?\",\"answer\":\"Incidence, prevalence, mortality, and DALYs come from the Global Burden of Disease Study 2023. Age-standardized rates, a quality of care index (QCI), and 5-year relative survival are calculated for integrated women’s cancers.\"},{\"question\":\"What were the main drivers of changes in women’s cancer burden from 1990 to 2023?\",\"answer\":\"The increase from 1990 to 2023 was primarily driven by population growth, while fertility and changes in DALY-related rates for breast and cervical cancers show opposite directions of association. Dominance analysis identified fertility, QCI, and survival-related factors as dominant predictors.\"}]","Burden of women's cancers in the group of twenty (G20) from 1990 to 2023 - epidemiological trends and impact from fertility, quality of care, and survival | PDF",1790057219,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d309c6b0e63dc2fb6d5c74278570a1ad.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2c95d7d295e8ff91686df2a487b48524.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/539ba5e30c95e7fef14b4aefa7cd3b3b.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5c91ca229065278f43996346eab72b5d.webp",980,1306]